StockWatch
·
Pharmaceuticals
ESOP29 May 2026, 09:40 pm

Rubicon Research Approves Employee Stock Option Scheme 2026

AI Summary

Rubicon Research Ltd's Board of Directors approved the formulation, adoption, and implementation of the 'Rubicon Research Limited - Employees Stock Option Scheme 2026' during its meeting on May 29, 2026. The scheme allows for the grant of stock options corresponding to 24,84,415 equity shares of ₹1 each to eligible employees, subject to member and regulatory approvals. This includes 6,72,162 shares from the existing Scheme 2022. The scheme complies with SEBI (SBEB) Regulations.

Key Highlights

  • Board approves Rubicon Research Limited - Employees Stock Option Scheme 2026.
  • Scheme covers 24,84,415 equity shares, including balance from Scheme 2022.
  • Exercise price will not be less than the face value of equity shares.
  • Scheme is compliant with SEBI (SBEB) Regulations.
  • Details of option exercise terms will be disclosed upon seeking member approval.